Laughren Psychopharm Consulting

Laughren Psychopharm Consulting is a private regulatory and clinical development consulting firm focused on psychopharmacology and psychiatric drug development. The firm appears to be led by Thomas P. Laughren, M.D., former Director of the FDA's Division of Psychiatry Products, and advises pharmaceutical and biotech companies on regulatory strategy, clinical trial design, end-of-Phase 2 planning, advisory committee preparation, and product labeling. Available public information indicates it supports development programs in psychiatry and broader CNS drug development rather than developing its own proprietary therapeutics. It is best characterized as a specialized healthcare consulting business serving drug sponsors in neuroscience and psychopharmacology.